Hiroshi Ogishima

442 total citations
22 papers, 223 citations indexed

About

Hiroshi Ogishima is a scholar working on Rheumatology, Epidemiology and Physiology. According to data from OpenAlex, Hiroshi Ogishima has authored 22 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 8 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Hiroshi Ogishima's work include Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Hiroshi Ogishima is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Systemic Lupus Erythematosus Research (8 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). Hiroshi Ogishima collaborates with scholars based in Japan and United States. Hiroshi Ogishima's co-authors include Isao Matsumoto, Takayuki Sumida, Takeshi Suzuki, Yuya Kondo, Hiroto Tsuboi, N. Umeda, Makoto Sugihara, Masanobu Horikoshi, Daisuke Goto and Tomoya Hirota and has published in prestigious journals such as Lara D. Veeken, Lupus and Clinical Rheumatology.

In The Last Decade

Hiroshi Ogishima

21 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroshi Ogishima Japan	11	142	47	44	39	34	22	223
R. Westhovens Belgium	7	119 0.8×	45 1.0×	27 0.6×	36 0.9×	37 1.1×	12	216
Fumika Honda Japan	10	101 0.7×	54 1.1×	28 0.6×	46 1.2×	59 1.7×	29	212
B. Jamard France	10	196 1.4×	47 1.0×	18 0.4×	31 0.8×	55 1.6×	22	287
Elisabetta Vantaggiato Italy	8	128 0.9×	34 0.7×	66 1.5×	26 0.7×	61 1.8×	14	290
Niall Jones Canada	7	152 1.1×	61 1.3×	30 0.7×	45 1.2×	31 0.9×	11	302
Hakan Emmungil Türkiye	11	105 0.7×	55 1.2×	38 0.9×	15 0.4×	51 1.5×	31	254
Françoise Fortenfant France	9	87 0.6×	49 1.0×	31 0.7×	59 1.5×	30 0.9×	31	239
Emma Shittu United Kingdom	5	108 0.8×	29 0.6×	33 0.8×	32 0.8×	54 1.6×	6	200
Stamatina Danielides United States	6	76 0.5×	32 0.7×	29 0.7×	11 0.3×	24 0.7×	11	212
Satoshi Takanashi Japan	10	187 1.3×	50 1.1×	17 0.4×	83 2.1×	32 0.9×	30	264

Countries citing papers authored by Hiroshi Ogishima

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Ogishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ogishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ogishima more than expected).

Fields of papers citing papers by Hiroshi Ogishima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ogishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ogishima. The network helps show where Hiroshi Ogishima may publish in the future.

Co-authorship network of co-authors of Hiroshi Ogishima

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ogishima. A scholar is included among the top collaborators of Hiroshi Ogishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ogishima. Hiroshi Ogishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Umeda, N., Isao Matsumoto, Yuya Kondo, et al.. (2015). Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases. Clinical Rheumatology. 35(5). 1181–1188. 19 indexed citations

2.

Kurata, Izumi, Hiroto Tsuboi, Hidenori Takahashi, et al.. (2015). A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated by corticosteroid and methotrexate: Fig. 1. Lara D. Veeken. 54(7). 1160–1160. 2 indexed citations

3.

Kurata, Izumi, Hiroto Tsuboi, Hidenori Takahashi, et al.. (2015). Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis. Internal Medicine. 54(12). 1553–1557. 6 indexed citations

4.

Tsuboi, Hiroto, Hiroshi Ogishima, Masahiro Yokosawa, et al.. (2015). [18F]fluorodeoxyglucose positron emission tomography/computed tomography can reveal subclinical prostatitis in a patient with IgG4-related disease. Lara D. Veeken. 54(6). 1113–1113.

5.

Hirota, Tomoya, Takeshi Suzuki, Hiroshi Ogishima, et al.. (2015). Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept. Modern Rheumatology. 26(1). 29–35. 7 indexed citations

6.

Yokosawa, Masahiro, Hiroto Tsuboi, Katsuhiro Nasu, et al.. (2014). Usefulness of MR imaging of the parotid glands in patients with secondary Sjögren's syndrome associated with rheumatoid arthritis. Modern Rheumatology. 25(3). 415–420. 11 indexed citations

7.

Segawa, Seiji, Daisuke Goto, Masanobu Horikoshi, et al.. (2014). Involvement of CD161+ Vδ1+ γδ T cells in systemic sclerosis: association with interstitial pneumonia. Lara D. Veeken. 53(12). 2259–2269. 8 indexed citations

8.

Tsuboi, Hiroto, Hiroyuki Takahashi, Masahiro Yokosawa, et al.. (2014). Clinical features of patients with IgG4-related disease complicated with perivascular lesions. Modern Rheumatology. 25(1). 105–109. 17 indexed citations

9.

Hagiwara, Shinya, Hiroto Tsuboi, Masahiro Yokosawa, et al.. (2014). Pulmonary nocardiosis in patients with connective tissue disease: A report of two cases. Intractable & Rare Diseases Research. 3(1). 25–28. 3 indexed citations

10.

Takahashi, Hidenori, Hiroto Tsuboi, Izumi Kurata, et al.. (2014). Predictors of the response to treatment in acute lupus hemophagocytic syndrome. Lupus. 24(7). 659–668. 12 indexed citations

11.

Tsuboi, Hiroto, Masahiro Yokosawa, Shinya Hagiwara, et al.. (2013). Clinicopathological features of IgG4-related disease complicated with orbital involvement. Modern Rheumatology. 24(3). 471–476. 24 indexed citations

12.

Ogishima, Hiroshi, Hiroto Tsuboi, N. Umeda, et al.. (2013). Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis. Modern Rheumatology. 24(1). 60–68. 30 indexed citations

13.

Suzuki, Takeshi, Masanobu Horikoshi, Makoto Sugihara, et al.. (2013). Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI. Modern Rheumatology. 23(4). 782–787. 10 indexed citations

14.

Ito, Satoshi, Hiroshi Ogishima, Yuya Kondo, et al.. (2013). Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases. Modern Rheumatology. 1 indexed citations

15.

Ito, Satoshi, Hiroshi Ogishima, Yuya Kondo, et al.. (2013). Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases. Modern Rheumatology. 24(1). 52–59. 18 indexed citations

16.

Suzuki, Takeshi, Masanobu Horikoshi, Makoto Sugihara, et al.. (2012). Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI. Modern Rheumatology. 23(4). 782–787. 12 indexed citations

17.

Tsuboi, Hiroto, Ei Wakamatsu, Mana Iizuka, et al.. (2010). Importance of serine727 phosphorylated STAT1 in IFNγ‐induced signaling and apoptosis of human salivary gland cells. International Journal of Rheumatic Diseases. 14(1). 86–91. 11 indexed citations

18.

Ogishima, Hiroshi, Satoshi Ito, Akito Tsutsumi, et al.. (2010). High‐dose unfractionated heparin therapy in a pregnant patient with antiphospholipid syndrome: a case report. International Journal of Rheumatic Diseases. 13(3). e32–5. 2 indexed citations

19.

Yamada, Hideyasu, Wataru Ishii, Satoshi Ito, et al.. (2007). Sarcoid myositis with muscle weakness as a presenting symptom. Modern Rheumatology. 17(3). 243–246. 5 indexed citations

20.

Sugihara, Makoto, Akito Tsutsumi, Eiji Suzuki, et al.. (2007). Effects of infliximab therapy on gene expression levels of tumor necrosis factor α, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis. Arthritis & Rheumatism. 56(7). 2160–2169. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact